Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract: a long-term comparative study.
Intestinal-type adenocarcinoma
Prognosis
Sinus carcinoma
Surgery
Journal
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937
Informations de publication
Date de publication:
16 Jan 2024
16 Jan 2024
Historique:
received:
30
08
2023
accepted:
29
12
2023
medline:
17
1
2024
pubmed:
17
1
2024
entrez:
16
1
2024
Statut:
aheadofprint
Résumé
Intestinal-type adenocarcinoma (ITAC) is a rare sinonasal malignancy. Curative treatment requires multidisciplinary approach, with surgical options consist of the endonasal endoscopic approach (EEA) and external surgery (EXTS). Here, we provide the post-operative and survival results from a single-center long-term follow-up. We report long-term follow-up of 92 ITAC cases treated between 1998 and 2018, treated with EEA (n = 40) or EXTS (n = 52). Survival estimates, post-operative complications and duration of hospitalization were compared between surgical modalities. Baseline characteristics were similar. A higher number of T4b tumors (16%), and subsequently more tumoral invasion (39%), was present in patients undergoing EXTS compared to EEA (3% and 18%, respectively). No difference in Barnes histology subtypes was noticed. Patients undergoing EEA had a shorter post-operative hospitalization stay versus EXTS (4 versus 7 days). Use of EEA was associated to improved disease-specific survival (DSS; 11.4 versus 4.4 years; HR Long-term follow-up in locally advanced ITAC demonstrates that resection by EEA is correlated with improved DSS compared to EXTS, especially for T3-4 tumors. No significant differences between both treatment modalities was observed regarding per- and post-operative complications, although hospitalization in patients undergoing EEA was shorter than for patients treated with EXTS. These results confirm that EEA should remain the preferred surgical procedure in operable cases of sinonasal ITAC.
Identifiants
pubmed: 38228884
doi: 10.1007/s00405-024-08447-w
pii: 10.1007/s00405-024-08447-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Sklar EM, Pizarro JA (2003) Sinonasal intestinal-type adenocarcinoma involvement of the paranasal sinuses. AJNR Am J Neuroradiol 24:1152–1155
pubmed: 12812944
pmcid: 8149027
Gallet P, Nguyen DT, Russel A, Jankowski R, Vigouroux C, Rumeau C (2018) Intestinal and non-intestinal nasal cavity adenocarcinoma: impact of wood dust exposure. Eur Ann Otorhinolaryngol Head Neck Dis 135:383–387. https://doi.org/10.1016/j.anorl.2018.08.012
doi: 10.1016/j.anorl.2018.08.012
pubmed: 30201443
Leivo I (2017) Intestinal-type adenocarcinoma: classification, immunophenotype, molecular features and differential diagnosis. Head Neck Pathol 11:295–300. https://doi.org/10.1007/s12105-017-0800-7
doi: 10.1007/s12105-017-0800-7
pubmed: 28321774
pmcid: 5550401
Georgel T, Jankowski R, Henrot P, Baumann C, Kacha S, Grignon B, Toussaint B, Graff P, Kaminsky MC, Geoffrois L, Vignaud JM (2009) CT assessment of woodworkers’ nasal adenocarcinomas confirms the origin in the olfactory cleft. AJNR Am J Neuroradiol 30:1440–1444. https://doi.org/10.3174/ajnr.A1648
doi: 10.3174/ajnr.A1648
pubmed: 19541776
pmcid: 7051534
Jankowski R, Georgel T, Vignaud JM, Hemmaoui B, Toussaint B, Graff P, Geoffrois L, Henrot P, Kaminsky MC (2007) Endoscopic surgery reveals that woodworkers’ adenocarcinomas originate in the olfactory cleft. Rhinology 45:308–314
pubmed: 18085026
Choussy O, Ferron C, Vedrine PO, Toussaint B, Lietin B, Marandas P, Babin E, De Raucourt D, Reyt E, Cosmidis A, Makeieff M, Dehesdin D (2010) Role of radiotherapy in the treatment of nasoethmoidal adenocarcinoma. Arch Otolaryngol Head Neck Surg 136:143–146. https://doi.org/10.1001/archoto.2009.212
doi: 10.1001/archoto.2009.212
pubmed: 20157059
Rampinelli V, Ferrari M, Nicolai P (2018) Intestinal-type adenocarcinoma of the sinonasal tract: an update. Curr Opin Otolaryngol Head Neck Surg 26:115–121. https://doi.org/10.1097/MOO.0000000000000445
doi: 10.1097/MOO.0000000000000445
pubmed: 29389737
Kennedy MT, Jordan RC, Berean KW, Perez-Ordonez B (2004) Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol 57:932–937. https://doi.org/10.1136/jcp.2004.016964
doi: 10.1136/jcp.2004.016964
pubmed: 15333652
pmcid: 1770431
Kim J, Chang H, Jeong EC (2018) Sinonasal intestinal-type adenocarcinoma in the frontal sinus. Arch Craniofac Surg 19:210–213. https://doi.org/10.7181/acfs.2018.01970
doi: 10.7181/acfs.2018.01970
pubmed: 30282432
pmcid: 6177672
Vergez S, du Mayne MD, Coste A, Gallet P, Jankowski R, Dufour X, Righini C, Reyt E, Choussy O, Serrano E, Crampette L, Debry C, de Gabory L (2014) Multicenter study to assess endoscopic resection of 159 sinonasal adenocarcinomas. Ann Surg Oncol 21:1384–1390. https://doi.org/10.1245/s10434-013-3385-8
doi: 10.1245/s10434-013-3385-8
pubmed: 24264517
Vergez S, Martin-Dupont N, Lepage B, De Bonnecaze G, Decotte A, Serrano E (2012) Endoscopic vs transfacial resection of sinonasal adenocarcinomas. Otolaryngol Head Neck Surg 146:848–853. https://doi.org/10.1177/0194599811434903
doi: 10.1177/0194599811434903
pubmed: 22261496
Weber RK, Hosemann W (2015) Comprehensive review on endonasal endoscopic sinus surgery. GMS Curr Top Otorhinolaryngol Head Neck Surg 14:Doc08. https://doi.org/10.3205/cto000123
doi: 10.3205/cto000123
pubmed: 26770282
pmcid: 4702057
Suh JD, Ramakrishnan VR, Chi JJ, Palmer JN, Chiu AG (2013) Outcomes and complications of endoscopic approaches for malignancies of the paranasal sinuses and anterior skull base. Ann Otol Rhinol Laryngol 122:54–59. https://doi.org/10.1177/000348941312200110
doi: 10.1177/000348941312200110
pubmed: 23472317
Barnes L (1986) Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 10:192–202. https://doi.org/10.1097/00000478-198603000-00006
doi: 10.1097/00000478-198603000-00006
pubmed: 3953940
Castelnuovo P, Turri-Zanoni M, Battaglia P, Antognoni P, Bossi P, Locatelli D (2016) Sinonasal malignancies of anterior skull base: histology-driven treatment strategies. Otolaryngol Clin N Am 49:183–200. https://doi.org/10.1016/j.otc.2015.09.012
doi: 10.1016/j.otc.2015.09.012
Duprez F, Madani I, Morbee L, Bonte K, Deron P, Domjan V, Boterberg T, De Gersem W, De Neve W (2012) IMRT for sinonasal tumors minimizes severe late ocular toxicity and preserves disease control and survival. Int J Radiat Oncol Biol Phys 83:252–259. https://doi.org/10.1016/j.ijrobp.2011.06.1977
doi: 10.1016/j.ijrobp.2011.06.1977
pubmed: 22027259
Castelnuovo P, Lambertoni A, Sileo G, Valentini M, Karligkiotis A, Battaglia P, Turri-Zanoni M (2021) Critical review of multidisciplinary approaches for managing sinonasal tumors with orbital involvement. Acta Otorhinolaryngol Ital 41:S76–S89. https://doi.org/10.14639/0392-100X-suppl.1-41-2021-08
doi: 10.14639/0392-100X-suppl.1-41-2021-08
pubmed: 34060523
pmcid: 8172109
Kawaguchi M, Kato H, Tomita H, Mizuta K, Aoki M, Hara A, Matsuo M (2017) Imaging characteristics of malignant sinonasal tumors. J Clin Med 5:5. https://doi.org/10.3390/jcm6120116
doi: 10.3390/jcm6120116
Chatelet F, Simon F, Bedarida V, Le Clerc N, Adle-Biassette H, Manivet P, Herman P, Verillaud B (2021) Surgical management of sinonasal cancers: a comprehensive review. Cancers. https://doi.org/10.3390/cancers13163995
doi: 10.3390/cancers13163995
pubmed: 34439150
pmcid: 8393312
Cracchiolo JR, Patel K, Migliacci JC, Morris LT, Ganly I, Roman BR, McBride SM, Tabar VS, Cohen MA (2018) Factors associated with a primary surgical approach for sinonasal squamous cell carcinoma. J Surg Oncol 117:756–764. https://doi.org/10.1002/jso.24923
doi: 10.1002/jso.24923
pubmed: 29193098
Debacker J, Huvenne W, Bonte K, De Neve W, Deron P, Ost P, Van Zele T, Vermeersch H, Duprez F (2018) Open surgery versus primary radiotherapy in T4b sinonasal carcinoma. B-ENT 14:93–99
Lund VJ, Clarke PM, Swift AC, McGarry GW, Kerawala C, Carnell D (2016) Nose and paranasal sinus tumours: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 130:S111–S118. https://doi.org/10.1017/S0022215116000530
doi: 10.1017/S0022215116000530
pubmed: 27841122
pmcid: 4873911
Ganly I, Patel SG, Singh B, Kraus DH, Bridger PG, Cantu G, Cheesman A, De Sa G, Donald P, Fliss D, Gullane P, Janecka I, Kamata SE, Kowalski LP, Levine P, Medina LR, Pradhan S, Schramm V, Snyderman C, Wei WI, Shah JP (2005) Complications of craniofacial resection for malignant tumors of the skull base: report of an International Collaborative Study. Head Neck 27:445–451. https://doi.org/10.1002/hed.20166
doi: 10.1002/hed.20166
pubmed: 15825205
Ganly I, Patel SG, Singh B, Kraus DH, Bridger PG, Cantu G, Cheesman A, De Sa G, Donald P, Fliss DM, Gullane P, Janecka I, Kamata SE, Kowalski LP, Levine PA, Medina Dos Santos LR, Pradhan S, Schramm V, Snyderman C, Wei WI, Shah JP (2005) Craniofacial resection for malignant paranasal sinus tumors: report of an international collaborative study. Head Neck 27:575–584. https://doi.org/10.1002/hed.20165
doi: 10.1002/hed.20165
pubmed: 15825201
Kasemsiri P, Prevedello DM, Otto BA, Old M, Ditzel Filho L, Kassam AB, Carrau RL (2013) Endoscopic endonasal technique: treatment of paranasal and anterior skull base malignancies. Braz J Otorhinolaryngol 79:760–779. https://doi.org/10.5935/1808-8694.20130138
doi: 10.5935/1808-8694.20130138
pubmed: 24474490
Verillaud B, Bresson D, Sauvaget E, Mandonnet E, Georges B, Kania R, Herman P (2012) Endoscopic endonasal skull base surgery. Eur Ann Otorhinolaryngol Head Neck Dis 129:190–196. https://doi.org/10.1016/j.anorl.2011.09.004
doi: 10.1016/j.anorl.2011.09.004
pubmed: 22321910
Alshammari DM, Almomen A, Taha M, Albahrna H, Alshammari S (2021) Quality of life and morbidity after endoscopic endonasal skull base surgeries using the sinonasal outcomes test (SNOT): a tertiary hospital experience. Int J Otolaryngol 2021:6659221. https://doi.org/10.1155/2021/6659221
doi: 10.1155/2021/6659221
pubmed: 34104196
pmcid: 8159648
Nicolai P, Battaglia P, Bignami M, Bolzoni Villaret A, Delu G, Khrais T, Lombardi D, Castelnuovo P (2008) Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: a 10-year experience. Am J Rhinol 22:308–316. https://doi.org/10.2500/ajr.2008.22.3170
doi: 10.2500/ajr.2008.22.3170
pubmed: 18588765
Van Gerven L, Jorissen M, Nuyts S, Hermans R, Vander Poorten V (2011) Long-term follow-up of 44 patients with adenocarcinoma of the nasal cavity and sinuses primarily treated with endoscopic resection followed by radiotherapy. Head Neck 33:898–904. https://doi.org/10.1002/hed.21556
doi: 10.1002/hed.21556
pubmed: 20967864
Meerwein CM, Brada MD, Soyka MB, Holzmann D, Rupp NJ (2022) Reappraisal of grading in intestinal-type sinonasal adenocarcinoma: tumor budding as an independent prognostic parameter. Head Neck Pathol. https://doi.org/10.1007/s12105-022-01410-3
doi: 10.1007/s12105-022-01410-3
pubmed: 35015192
pmcid: 9424375
Meccariello G, Deganello A, Choussy O, Gallo O, Vitali D, De Raucourt D, Georgalas C (2016) Endoscopic nasal versus open approach for the management of sinonasal adenocarcinoma: a pooled-analysis of 1826 patients. Head Neck 38(Suppl 1):E2267-2274. https://doi.org/10.1002/hed.24182
doi: 10.1002/hed.24182
pubmed: 26335008
Van Gerven L, Vander Poorten V, Jorissen M (2011) Adenocarcinomas of the sinonasal tract: current opinion. B-ENT 7(Suppl 17):15–20
pubmed: 22338370
Franchi A, Miligi L, Palomba A, Giovannetti L, Santucci M (2011) Sinonasal carcinomas: recent advances in molecular and phenotypic characterization and their clinical implications. Crit Rev Oncol Hematol 79:265–277. https://doi.org/10.1016/j.critrevonc.2010.08.002
doi: 10.1016/j.critrevonc.2010.08.002
pubmed: 20870420
Llorente JL, Lopez F, Suarez C, Hermsen MA (2014) Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances. Nat Rev Clin Oncol 11:460–472. https://doi.org/10.1038/nrclinonc.2014.97
doi: 10.1038/nrclinonc.2014.97
pubmed: 24935016